Accès gratuit
Volume 62, Numéro 3, Mai-Juin 2007
XXIIes Rencontres Nationales de Pharmacologie Clinique, Giens 7-10 octobre 2006
Page(s) 211 - 216
Section Affaires réglementaires/Regulatory System
Publié en ligne 6 septembre 2007
  1. Rhodes R, Strain JJ. Whistleblowing in academic medicine. J Med Ethics 2004; 30(1): 35-9 [Google Scholar]
  2. Kansu E, Ruacan S. Research ethics and scientific misconduct in biomedical research. Acta Neurochir Suppl 2002; 83: 11-5 [PubMed] [Google Scholar]
  3. de Pracontal M. L'imposture scientifique en dix leçons. Paris: Seuil; 2005 [Google Scholar]
  4. Lock S, Wells F. Fraud and misconduct in medical research. London: BMJ books; 2002 [Google Scholar]
  5. Broad W, Wade N. La souris truquée. Enquête sur la fraude scientifique. Paris: Seuil; 1987 [Google Scholar]
  6. Mathews AW. Fraud, errors taint a key study of widely used Sanofi drug; despite some faked results, FDA approves antibiotic; one doctor's cocaine use; company defends safety. Wall St J (East Ed) 2006: A1, A12 [Google Scholar]
  7. Couzin J, Schirber M. Scientific misconduct. Fraud upends oral cancer field, casting doubt on prevention trial. Science 2006; 311(5760): 448-9 [Google Scholar]
  8. Mathews AW, Wonacott P. Playing detective: at medical journal, editor finds truth hard to track down; termite-eaten data plague Dr. Smith's 12-year probe of an Indian researcher. Wall St J (East Ed) 2005: A1, A2 [Google Scholar]
  9. Al-Marzouki S, Roberts I, Marshall T, et al. The effect of scientific misconduct on the results of clinical trials: a Delphi survey. Contemp Clin Trials 2005; 26(3): 331-7 [Google Scholar]
  10. Ranstam J, Buyse M, George SL, et al. Fraud in medical research: an international survey of biostatisticians. ISCB Subcommittee on Fraud. Control Clin Trials 2000; 21(5): 415-27 [Google Scholar]
  11. Gardner W, Lidz CW, Hartwig KC. Authors' reports about research integrity problems in clinical trials. Contemp Clin Trials 2005; 26(2): 244-51 [Google Scholar]
  12. Safer DJ. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials. J Nerv Ment Dis 2002; 190(9): 583-92 [Google Scholar]
  13. Buyse M, George SL, Evans S, et al. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. Stat Med 1999; 18(24): 3435-51 [Google Scholar]
  14. Al-Marzouki S, Evans S, Marshall T, et al. Are these data real? Statistical methods for the detection of data fabrication in clinical trials. BMJ 2005; 331(7511): 267-70 [Google Scholar]
  15. Bostanci A, Vogel G. Research misconduct. German inquiry finds flaws, not fraud. Science 2002; 298(5598): 1531-3 [Google Scholar]
  16. DeMets DL. Distinctions between fraud, bias, errors, misunderstanding, and incompetence. Control Clin Trials 1997; 18(6): 637-50; discussion 661-6 [Google Scholar]
  17. Nylenna M, Simonsen S. Scientific misconduct: a new approach to prevention. Lancet 2006; 367(9526): 1882-4 [Google Scholar]
  18. Dyer O. GP struck off for fraud in drug trials. BMJ 1996; 312 (7034): 798 [letter] [Google Scholar]
  19. [Google Scholar]
  20. [Google Scholar]
  21. [Google Scholar]